HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Thymoma Cancer

Thymoma Cancer

Thymoma, a rare type of cancer originating in the thymus gland, poses significant challenges in diagnosis and treatment. While research on thymoma remains relatively limited compared to more common cancers, recent advancements are shedding light on its complexities. Scientists are delving into the genetic and molecular mechanisms driving thymoma's development, seeking targeted therapies tailored to its specific characteristics. Immunotherapy, which harnesses the body's immune system to fight cancer, shows promise in treating thymoma by bolstering the immune response against tumor cells. Additionally, advancements in imaging technologies enhance early detection and monitoring of thymoma progression. Collaborative efforts among researchers, clinicians, and patients are crucial in advancing our understanding and improving outcomes for individuals battling thymoma.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp